We are thrilled to announce that SkinIO has joined the iLab as the fourth company to participate in our residency program. The iLab recognized that during the pandemic, patients were putting off preventative care, and long wait times to see a dermatologist were only increasing. Our partners were looking for innovative teledermatology solutions that would provide access and improve quality of care for their patients and members, and the iLab immediately saw that SkinIO stood out as a leader in the teledermatology space.

SkinIO is a HIPAA-compliant, AI-driven, virtual skin cancer screening platform that allows patients to scan and securely map their skin using a smartphone app. These images are reviewed remotely by expert dermatologists and are connected to care if they require in-person follow-up.

While at the iLab, SkinIO will build strong relationships with our partners and work with experts to help refine their product and workflow. SkinIO will conduct a pilot with Capital Blue Cross through the iLab in the spring with hopes to attract close to 1,000 members.

Learn more about SkinIO and the iLab program at
https://www.prweb.com/releases/teledermatology_company_is_newest_resident_of_smart_health_innovation_lab/prweb18451688.htm#